Spiracur raises $35mm in third round
Executive Summary
In what appears to be its third round, Spiracur Inc. (developing a portable negative pressure wound therapy device) has raised $35mm. New investor Maverick Capital led (and takes a seat on the company's board) and was joined by Pinnacle Ventures and returning backers De Novo Ventures, Kleiner Perkins Caufield & Byers, and New Leaf Venture Partners. Spiracur's last-announced fundraising was a $20.3mm Series B round in July 2009.
Deal Industry
- Medical Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice